LYTIX — Lytix Biopharma AS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Lytix Biopharma AS, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	PRESS	ARS
Standards:	NAS	NAS	IFRS	NAS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28.4	197	145	50.5	131
Net Total Receivables	4.17	5.68	6.74	12.8	13.1
Total Other Current Assets
Total Current Assets	32.6	203	152	63.3	144
Net Property, Plant And Equipment	—	2.14	1.38	0.11	2.63
Other Long Term Assets
Total Assets	32.6	205	153	63.4	147
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12.7	14.2	17.8	12.1	36.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.7	15.5	18.2	12.1	38.6
Common Stock
Additional Paid In Capital
Other Equity
Total Equity	19.9	190	135	51.4	108
Total Liabilities & Shareholders' Equity	32.6	205	153	63.4	147
Total Common Shares Outstanding